Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
11.74
+0.46 (4.08%)
At close: Jul 26, 2024, 4:00 PM
11.54
-0.20 (-1.70%)
After-hours: Jul 26, 2024, 6:35 PM EDT

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Market Capitalization
687523462596936764
Upgrade
Market Cap Growth
96.45%13.23%-22.48%-36.35%22.51%-
Upgrade
Enterprise Value
815535464461758807
Upgrade
Last Close Price
10.629.1311.2219.6733.2231.14
Upgrade
PE Ratio
--2.32-2.22-5.06-8.55-1.39
Upgrade
PS Ratio
264.92766.44----
Upgrade
PB Ratio
-4.09-7.18-6.178.254.823.35
Upgrade
P/FCF Ratio
-3.61-3.75-3.13-4.00-13.23-20.84
Upgrade
P/OCF Ratio
-3.64-3.80-3.15-4.01-13.43-20.92
Upgrade
EV/Sales Ratio
314.06785.10----
Upgrade
EV/EBITDA Ratio
-3.26-3.21-2.70-3.43-6.05-29.55
Upgrade
EV/EBIT Ratio
-3.25-3.20-2.69-3.41-6.03-29.55
Upgrade
EV/FCF Ratio
-3.99-3.85-3.15-3.10-10.72-22.03
Upgrade
Debt / Equity Ratio
-3.22-6.13-2.761.270.250.10
Upgrade
Debt / FCF Ratio
-2.84-3.20-1.40-0.61-0.69-0.64
Upgrade
Asset Turnover
0.010.00----
Upgrade
Quick Ratio
7.509.885.929.695.1865.04
Upgrade
Current Ratio
7.8310.256.129.865.2568.20
Upgrade
Return on Equity (ROE)
----108.01%-61.14%-225.11%
Upgrade
Return on Assets (ROA)
-51.74%-36.14%-60.85%-34.85%-28.44%-13.23%
Upgrade
Return on Capital (ROIC)
-57.17%-41.42%-73.00%-41.51%-31.75%-13.54%
Upgrade
Earnings Yield
-35.89%-38.57%-42.83%-24.16%-13.79%-33.40%
Upgrade
FCF Yield
-24.50%-26.63%-31.97%-24.98%-7.56%-4.80%
Upgrade
Buyback Yield / Dilution
-37.82%-31.11%-5.72%-11.36%-192.32%-87.83%
Upgrade
Total Shareholder Return
-37.82%-31.11%-5.72%-11.36%-192.32%-87.83%
Upgrade
Source: S&P Capital IQ. Standard template.